BioNexus Gene Lab Corp — Cash Flow (NASDAQ:BGLC)

Financials

Cash from operating activities 552.68 K9 161544.03 K-1.3 M-2.23 M -2.72 M Cash from investing activities 1.32 M-490.57 K-450.5 K-382.58 K418.2 K 1.5 M Cash from financing activities 4 947-28.22 K115.96 K5.75 M144.97 K 30.91 K Free cash flow 131.06 K5 999489.86 K-1.3 M-2.46 M -2.76 M

新闻

BioNexus Gene Lab任命Fidelion首席商务官

BioNexus Gene Lab appoints commercial officer at Fidelion

BioNexus Gene Lab完成与Fidelion Diagnostics的战略交易

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

BioNexus Gene Lab股价在获得5亿美元股权融资后下跌

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

BioNexus Gene Lab股价在获得5亿美元股权融资后上涨

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab股价在达成MRD检测战略协议后飙升

BioNexus Gene Lab与合作伙伴达成协议商业化液体活检平台

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform